This 2018 retrospective cohort study evaluated 5,416 ovarian cancer patients to investigate the association between statin use and overall survival. The study found that statin use correlated with a significant improvement in overall survival, particularly in patients with non-serous histologic subtypes. The proposed mechanisms include statins' anti-inflammatory, anti-proliferative, and pro-apoptotic
